Category: Baxter InternationalSyndicate content

ConMed ripe for M&A | The week in medtech M&A

May 27, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: ConMed ripe for M&A spree; Baxter looks to growth post-Baxalta spinout; Sorin shareholders OK Cyberonics Merger

Analyst: ConMed ripe for M&A spree

May 19, 2015 by Fink Densford

Analyst: ConMed ripe for M&A spree

Baxter looks to growth post-Baxalta spinout

May 20, 2015 by Mark Hollmer

Baxter International looks to sales and margin growth after it spins out its biopharmaceutical arm as Baxalta, likely augmented with acquisitions.

Baxter looks to growth post-Baxalta spinout

Baxter (NYSE:BAX) said it plans to boost its sales and margin growth after the planned July 1 spinout of its biopharmaceutical division as Baxalta.

Baxter logs Q1 sales, earnings beats

April 23, 2015 by Brad Perriello

Baxter International reports 1st-quarter results that top its own and Wall Street's sales & earnings expectations.

Baxter logs Q1 sales, earnings beats

Investors bid shares of Baxter (NYSE:BAX) up this morning after the healthcare giant reported sales and earnings that beat expectations on Wall Street and its own prior guidance, despite declines for both numbers.

BAX drops FloSeal case against J&J | Medtech legal news for the week of April 13, 2015

April 13, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Baxter drops FloSeal case against J&J; Feds: We got $119m in fraud penalties from medtech companies last year; Insurer, DJO Global settle pain pump suit

Baxter drops FloSeal case against J&J

April 6, 2015 by Brad Perriello

YYmeta

On-X Life Technologies wins expanded labeling indication from FDA | Regulatory news for the week of April 6, 2015

April 7, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA expands indication for On-X Life's heart valve; More CT scanner problems for Philips Healthcare; Augmenix wins FDA nod for SpaceOar prostate treatment; Biotronik launches Pantera Pro balloon catheter in Europe; Baxter wins CE Mark for home dialysis device

FDA expands indication for On-X Life's heart valve

April 3, 2015 by Mark Hollmer

Baxter drops FloSeal case against J&J

April 6, 2015 by Brad Perriello

Baxter International drops its patent suit against Johnson & Johnson over the technology behind Baxter's FloSeal hemostasis device.

YYmeta

Baxter wins CE Mark for home dialysis device

April 2, 2015 by Brad Perriello

Baxter International wins CE Mark approval in the European Union for its HomeChoice Claria device for home peritoneal dialysis treatments.

Baxter wins CE Mark for home dialysis device